chrisvoncsefalvay/vaers-outcomes huggingface dataset:
injection site pain/pain/ residual pain at the injection site; tiredness; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain and tiredness. On an unknown date, the outcome of the injection site pain and tiredness were unknown.   It was unknown if the reporter considered the injection site pain and tiredness to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported. The patient received the 1st dose of Shingrix vaccine in the Fall of 2018 in left arm. He thought that he received it in the afternoon. He experienced a lot of pain at the injection site after receiving the vaccination.  This pain occurred for months after receiving the product and he describes that the pain was cyclic- he would had pain, it would stop and then start again.  He said that now, when he gets tired, he feels residual pain at the injection site.  The reporter did not consent to follow up.
Have congestion in lung now; This spontaneous case was reported by an other health care professional and describes the occurrence of PULMONARY CONGESTION (Have congestion in lung now) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PULMONARY CONGESTION (Have congestion in lung now) (seriousness criterion medically significant). At the time of the report, PULMONARY CONGESTION (Have congestion in lung now) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment information was provided. Scheduled for booster shot this Afternoon. Patient don't have temperature.  Company Comment: This case refers to a patient of unspecified age and gender with no known medical history who experienced the unexpected event of Pulmonary congestion on an unspecified date after a dose of mRNA-1273 vaccine. No causality assessment was provided by the reporter. The benefit-risk relationship of mRNA-1273 is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This case refers to a patient of unspecified age and gender with no known medical history who experienced the unexpected event of Pulmonary congestion on an unspecified date after a dose of mRNA-1273 vaccine. No causality assessment was provided by the reporter. The benefit-risk relationship of mRNA-1273 is not affected by this report.
1.) Ischemic heart disease; abnormal stress test and cardiac cath; 3 vessel coronary artery by-pass graft surgery. 2.) Autoimmune hepatitis
"Pfizer-Bio-Tech COVID-19 Vaccine EUA" ¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬Individual came in Clinic for 2 nd dose of Covid-19 Vaccine.  When individual was asked if this is visit for the second dose of Pfizer vaccine she said yes. She did not have her vaccination card for the first dose on hand.  Her vaccine card was misplaced.  I give the Pfizer vaccine then proceeded to complete the client vaccine card. I went to computer to get the 1 st information that is when I noticed she had received Moderna as the 1st dose. Patient did not report any reaction to the vaccine during her 30-minute wait period.
Swollen lymph nodes within approx 24 hrs of vaccine on left side between under arm a breast. - still extremely swollen. Fever starting approx 12-16 hours later lasting 24 hours  . Note: I had extreme lymph node swelling in right side of my neck following my first shot ( nothing for second shot)
brain fog; itchy spot; headache; Little bit nauseous; feels tired; chills; Felt like almost passed away; Fast heart palpitations; Slept all next day more than usual; pain in her left jaw; diarrhea; A spontaneous report was received from a Consumer herself concerning as a 79 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fast heart palpitations, bad headache, felt like she almost passed away, slept all next day more than usual and had chills, pain in her left jaw, little bit nauseous, itchy spot in the injection arm, diarrhea, feels tired and brain fog.   The patient's historical conditions were mentioned as High blood pressure and cholesterol. No relevant concomitant medications were reported.   On 27 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 001A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 01 Mar 2021, the patient experienced fast heart palpitations, bad headache, felt like she almost passed away which was a serious condition and considered as medically significant. Slept all next day more than usual and had chills, pain in her left jaw, little bit nauseous, itchy spot in the injection arm, diarrhea, feels tired.   On an unknown date patient experienced brain fog.   On 01 mar 2021, blood pressure was raised to 199/120, cardiac stress test as normal and low pulse rate.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was unknown.  The headache, tired and brain fog was ongoing and for other events were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
OTHER SYMPTOMS EXPERIENCED; BODY CHILLS; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported. We are unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced other symptoms experienced. On MAR-2021, the subject experienced body chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body chills and other symptoms experienced was not reported. This report was non-serious.
Broke out in red flat rash on inner aspect of upper arms within minutes of receiving vaccines.   Flushed, no shortness of breath.  Given Epinephrine IM. 911 transported to ER.  Given Benadryl on route to ER and IV push meds in ER.  Rash progressed down arms to palms and changed from flat red to hives even on palms.  Released from ER after several hours with a 6 pack of po steroids and pepcid.
First reaction occurred earlier about 1 week after the injection consisted of generalized dizziness.  Lasted for about a month. Second and more serious reaction began around 8-20-20,  of burning of the bottom of both feet. It has progressively gotten worse and radiates up the side of both lower legs.  This is  Peripheral Neuropathy.   I am schedule to consult with a neurologist on Oct 6, 2020;  Dr. I have discovered on a clinic connect that there are multiple number of other people that have experienced the same sequela.  This needs to be fully investigated.
Fever 100.1F Headache Body aches  Chills Naussea Painful knees
Information has been received from a registered nurse referring to an unspecified number of patients of unknown ages and gender. Information about medical history and concurrent condition was not reported. On unknown dates since 13-JUL-2015 the patients were administered with GARDASIL 9 (lot# L004741 with expiration date of 04-MAR-2017, lot# K026246 with expiration date of 28-JAN-2017) (strength, dose and route unspecified), which were exposed to temperatures outside of the recommended range. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
numbness,numbness persisted for several hours,on and off numbness in the left arm; pressure in my left side; pressure was felt along my carotid artery,pressure was felt toward the back of my neck; pressure was felt up toward the base of my skull; tingling in my lips; my left hand experiencing a strange pain in my fingers; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness,numbness persisted for several hours,on and off numbness in the left arm), DISCOMFORT (pressure in my left side), MUSCULOSKELETAL DISCOMFORT (pressure was felt along my carotid artery,pressure was felt toward the back of my neck), HEAD DISCOMFORT (pressure was felt up toward the base of my skull) and PARAESTHESIA ORAL (tingling in my lips) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness,numbness persisted for several hours,on and off numbness in the left arm), DISCOMFORT (pressure in my left side), MUSCULOSKELETAL DISCOMFORT (pressure was felt along my carotid artery,pressure was felt toward the back of my neck), HEAD DISCOMFORT (pressure was felt up toward the base of my skull), PARAESTHESIA ORAL (tingling in my lips), PAIN IN EXTREMITY (my left hand experiencing a strange pain in my fingers) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, HYPOAESTHESIA (numbness,numbness persisted for several hours,on and off numbness in the left arm), DISCOMFORT (pressure in my left side), MUSCULOSKELETAL DISCOMFORT (pressure was felt along my carotid artery,pressure was felt toward the back of my neck), HEAD DISCOMFORT (pressure was felt up toward the base of my skull), PARAESTHESIA ORAL (tingling in my lips), PAIN IN EXTREMITY (my left hand experiencing a strange pain in my fingers) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-253095 (Patient Link).
30 minutes after vaccine, during volleyball practice, patient became light-headed, did not pass out. Felt fine after a few minutes. The next day felt dizzy, achy, chills, bad headache, general discomfort, no temp. Relieved with 2 ADVIL.
The evening of my shot I felt like I was getting a cold. Nose stuffed, chills, etc., but when I woke up, I felt nauseated and felt two hard lumps beneath my tongue, not PART of the tongue, but a short space from the bottom gumline.  I could feel it with my tongue and also see it in the mirror. Still don't know what this is. I ate a banana and again feel nauseated and my eyes are hurting...like burning and headache as well.
7/23 5:30PM Noticed swelling upper lip, rash and mild itching posterior trunk. No medication taken. 7/24 AM noticed rash anterior trunk, some swelling lower lip. Took Benadryl 25mg twice that day. 7/25 Rash lip swelling cleared; took 2 more doses Benadryl denies fever, respiratory problems.
ache in the upper arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (ache in the upper arm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol, Blood pressure high and Platelets abnormal. Concomitant products included MAGNESIUM, CALCIUM and VITAMIN D NOS for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (ache in the upper arm). At the time of the report, PAIN IN EXTREMITY (ache in the upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medications reported since an unknown start date included medicines for cholesterol, platelet and blood pressure indications.  Treatment of events was not reported though the patient did call to confirm if she could take acetaminophen (Tylenol).
After about ten minutes of getting the shot, I was sitting down & suddenly started to feel   dizzy/faint like. I then spoke up to let the staff know. They brought me a bottle of water but after one drink, I dropped it and began "seizing", she said it looked like I may have had a mini seizure, which I've never had in my life. After that stopped, my muscles in my legs, ankles, hands, arms, we're stuck stuff and sore. It was about 20 minutes before they began to feel better. My body was sore for about two weeks after, as if I had started a new workout routine.
ERROR: SECOND DOSE ADMINISTERED AT 17 DAYS. (First dose administered 4/21/21. Second dose administered 5/8/21.) Event discovered by PCP and forwarded to  Health District for VAERS reporting. Signs and symptoms: None known Diagnosis and treatment: None known Outcome: No adverse reaction reported
A bruise (1.5x2in) two inches below the administration site on the bicep area.  The patient determines it was due to the adverse reaction although her doctor states that it was due to her age
This patient DID NOT have an adverse event. She was given a 3rd dose at a large clinic because her first dose had been entered in under the wrong date of birth, so we were not aware of her actual first dose. She did not report any adverse events in relation to this administration error.
gen sz occurred w/in 1hr p/vax;sz activity lasted for 3min;temp was 103 when arrived home;
"Pfizer-BioNTech COVID-19 Vaccine EUA" -- pt admitted for covid-19 after 1 dose of covid-19 vaccine  Pt received covid-19 vaccine on 3/18/2021.  Admitted to hosp on 4/2/2021 with c/o SOBx6dyas, with intermittent chest tightness+pleuritic chest pain+ productive cought with yellow sputum + chills, loss of taste and smell, myalgia, sore throat, headache.  Spouse was tested positive one week PTA.   Hypoxia on RA at home with 88% readings.  Received Remdesivir x5days and Dexamethasone; 4/2/2021 89% O2sat on RA, put on 2-3L NC and O2 sat improved to 95-98% 4/3/2021 on 3L NC, O2 sat 97-98% 4/4/2021 on 2L NC, O2 sat 94-95% 4/5-4/6 on 2L NC, O2 sat 97-99% 4/7/2021 O2 sat 96-99% on RA
Information has been received from a physician concerning an approximately 30 year old female healthcare worker who was vaccinated with a second dose of varicella virus vaccine live. The physician reported that the patient subsequently developed chicken pox and had a negative varicella titer two weeks after her second dose of varicella virus vaccine live. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
After administration, C/O lightheaded, flushed, nauseated. Lasted approximately 10 min. Relieved by lying down.
No adverse event; Patient had Moderna bivalent booster vaccine for their first primary dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient had Moderna bivalent booster vaccine for their first primary dose) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Oct-2022, the patient experienced INCORRECT DOSE ADMINISTERED (Patient had Moderna bivalent booster vaccine for their first primary dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient had Moderna bivalent booster vaccine for their first primary dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Patient had Moderna bivalent booster vaccine for their first primary dose).    No concomitant information provided Two patients walked into the Pharmacy the previous day and received the moderna bivalent booster vaccine for their first primary dose. The patients had never received a primary series of the Moderna Covid-19 vaccine. No treatment information provided   Reporter did not allow further contact
Resident complained of weakness, low grade fever, and tachycardiac which led to a fall with a fracture of her tib/fib. Has not returned to baseline.
think that it is they have been infected with actual covid-19; Arm gets so sore; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (think that it is they have been infected with actual covid-19) and VACCINATION SITE PAIN (Arm gets so sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced VACCINATION SITE PAIN (Arm gets so sore). On an unknown date, the patient experienced SUSPECTED COVID-19 (think that it is they have been infected with actual covid-19). At the time of the report, SUSPECTED COVID-19 (think that it is they have been infected with actual covid-19) and VACCINATION SITE PAIN (Arm gets so sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that Vaccine is a Spike Protein and Put covid into the vaccine and then injected into their body. Patient scheduled for dose 2 on 02-Nov-2021. No medical query is raised since the reporter did not provide consent for follow-up. Concomitant information was not reported. Treatment information was not reported   Reporter did not allow further contact; Sender's Comments: This case concerns a patient of unknown age and gender with no medical history disclosed, who experienced the unexpected non-serious adverse event of special interest of suspected COVID-19. The event occurred on unknown date after the first dose of Spikevax (Moderna COVID-19 vaccine). The rechallenge was unknown since the events occurred after the first dose and there is no information about the second. The benefit-risk relationship of Spikevax (Moderna COVID-19 vaccine) is not affected by this report.
Red, swollen and painful mid-half of left upper arm, 2-3 days after immunization.
Tired; Stomach ache; eyes were itching; itchy throat; flushing; itching; ears were hot to touch; agitation; This is a spontaneous report from a contactable consumer (Patient). A 66-years-old female non pregnant patient received bnt162b2 (Pfizer, Solution for injection, Lot Number: en6203), dose 1 via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:00 (at the time of 66-years-old), as first dose, single, for covid-19 immunisation. Medical history included high bp (blood pressure) and known allergies to codine, latex, morphine, penicillin. Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID-19, prior vaccination. Patient has not been tested for COVID-19, post vaccination. The patient previously took cortisone, hydrocodone, morphine and had allergies. Concomitant medications included lisinopril at 5mg; colecalciferol (VITAMIN D, strength: 10000 IU) at 10000 iU; fish oil; curcuma longa (TURMERIC). It was reported that 24 hours after the injection patient had flushing, itching, agitation, itchy throat, my ears were hot to touch and very itchy, my eyes were itching as well on 23Fe2021 14:00. I took allergy medicine, day three horrible stomach ache (25Feb2021), not flu-like it was the pain associated with past allergic reactions to pain meds. The patient did not feel the need to throw up the fourth day was just tired (26Feb2021). Therapeutic measures were taken as a result of itchy throat, flushing, itching, ears were hot to touch, agitation, eyes were itching. The outcome of the events was resolved.   No follow-up attempts are possible. No further information is expected.
c/o right eyeball reddness,fatigue,injection site sore and swollen,had flushing right after injection given. Narrative:
This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of   in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case concerns a female of unknown age with a nonserious expected event of lymphadenopathy.  Treatment not reported.  Event outcome unknown. Based on the current available information and temporal association between the use of the product and the start date of the lymphadenopathy, a causal relationship cannot be excluded.; Reporter's Comments: This case concerns a female of unknown age with a nonserious expected event of lymphadenopathy.  Treatment not reported.  Event outcome unknown. Based on the current available information and temporal association between the use of the product and the start date of the lymphadenopathy, a causal relationship cannot be excluded.
This spontaneous report as received from a registered nurse refers to hundreds of patients of unknown aeg. Medical history and drug allergies were not reported. On an unknown date the patients were vaccinated with GARDASIL (5 ml, intramuscular). Lot number was not reported. The reporter stated they were administering the vaccine with a one inch needle. Concomitant therapies were not reported. Nurse referred patients complain that GARDASIL was painful when it was administrated, and they wince in pain when it was given. More girls than boys found the vaccination painful. Patients referred they could feel the medicine going into their arm. Also, the arm feels numb and weak right after administration. Nurse stated she had noticed this type of GARDASIL reaction in hundreds of patients. The patients sought medical attention in office. The reporter stated the symptoms did not seem to persist; short term duration, since patients did not call the office to complain afterwards. The outcome of the events was reported as recovered. Causality between the events and GARDASIL was not reported. Additional information is not expected.